A prospective stratified case-cohort study on statins and multiple adverse events in Japan von Ooba, Nobuhiro, Sato, Tsugumichi, Wakana, Akira, Orii, Takao, Kitamura, Masaki, Kokan, Akira, Kurata, Hideaki, Shimodozono, Yoshihiro, Matsui, Kenichi, Yoshida, Hiroshi, Yamaguchi, Takuhiro, Kageyama, Shigeru, Kubota, Kiyoshi

Volltext

2．Consideration of Signal Management Process von KOKAN, Akira, KAWAGUCHI, Genta

Volltext

A Prospective Stratified Case-Cohort Study on Statins and Multiple Adverse Events in Japan: e96919 von Ooba, Nobuhiro, Sato, Tsugumichi, Wakana, Akira, Orii, Takao, Kitamura, Masaki, Kokan, Akira, Kurata, Hideaki, Shimodozono, Yoshihiro, Matsui, Kenichi, Yoshida, Hiroshi

Volltext

2．Consideration of Signal Management Process von KOKAN, Akira, KAWAGUCHI, Genta

Volltext

3. A Review of Completed Activities of "The Task Force to Make an Ideal Pharmacovigilance Plan (PVP) in Japan" : Evaluation of the Published Pharmacovigilance Plan (PVP) by JSPE's... von KOKAN, Akira, KUBOTA, Kiyoshi

Volltext

Pharmacovigilance and Risk Management von KOKAN, Akira

Volltext

Good Pharmacovigilance Planning in Japan: Proposals from the “Task Force for Good Pharmacovigilance Planning in Japan” of Japanese Society for Pharmacoepidemiology (JSPE) von KOMIYAMA, Osamu, AOKI, Kotonari, KOKAN, Akira, KUBOTA, Kiyoshi

Volltext

3. A Review of Completed Activities of “The Task Force to Make an Ideal Pharmacovigilance Plan (PVP) in Japan” : Evaluation of the Published Pharmacovigilance Plan (PVP) by JSPE's... von KOKAN, Akira, KUBOTA, Kiyoshi

Volltext

Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements: The Final Report from the Task Force von KOKAN, Akira, KAI, Yasuhiko, KAGEYAMA, Shigeru, KUBOTA, Kiyoshi, TSUTANI, Kiichiro, NISHI, Toshimichi, MAEDA, Rei, MASADA, Mikio, MIYAKAWA, Kou

Volltext

Guidelines for Submitting Adverse Event Reports for Publication von Kokan, Akira, Takahashi, Mio, Higashi, Tomoko, Mitani, Takuya, Kikuchi, Nobutaka

Volltext

2．シグナル管理の在り方について von 古閑, 晃, 川口, 源太

Volltext

Pharmacovigilance and Risk Management von KOKAN, Akira

Volltext

Creating a Checklist and a Survey on Research That Used the Japanese Adverse Drug Event Report Database von Sakai, Takamasa, Wada, Yukito, Kokan, Akira, Tanabe, Kouichi, Goto, Nobuyuki, Ohtsu, Fumiko

Volltext

Checklist and Guidance of Scientific Approach to Developing Pharmacovigilance Plan (PVP) in Japan: A Report from a Task Force of JSPE von KUBOTA, Kiyoshi, AOKI, Kotonari, URUSHIHARA, Hisashi, KAGIMURA, Tatsuo, KAGEYAMA, Shigeru, KOIDE, Daisuke, KOKAN, Akira, SATO, Tsugumichi, NAKAMURA, Toshiaki, NAKAJIMA, Ken, HATANAKA, Naoya, HIRAKAWA, Takeshi, MIYAKAWA, Kou, MOCHIZUKI, Mayumi

Volltext

日本の有害事象自発報告データベース（JADER）を用いた研究におけるチェックリストの作成と実態調査 von 酒井, 隆全, 和田, 侑輝人, 古閑, 晃, 田辺, 公一, 後藤, 伸之, 大津, 史子

Volltext

Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements von KOKAN, Akira, KAI, Yasuhiko, KAGEYAMA, Shigeru, KUBOTA, Kiyoshi, TSUTANI, Kiichiro, NISHI, Toshimichi, MAEDA, Rei, MASADA, Mikio, MIYAKAWA, Kou

Volltext

Information: Recommendations for developing postmarketing surveys and clinical investigations using SS-MIX standardized storage von Kubota, Kiyoshi, Koide, Daisuke, Kokan, Akira, Kageyama, Shigeru, Ueda, Shinichiro, Kimura, Michio, Toyoda, Ken, Ohashi, Yasuo, Ohtsu, Hiroshi, Aoki, Kotonari, Komiyama, Osamu, Shomoto, Koji, Hirakawa, Takeshi, Shinoda, Hidenori, Sato, Tsugumichi

Volltext

A Report from Task Force on Pharmacoepidemiology and Pharmaceutical Industory: 安全性監視計画の現実と課題　-事例からみた一考察 von MATSUI, Kenichi, IMAI, Keiji, UEHARA, Hiromi, KOKAN, Akira, NISHI, Toshimichi, MARUI, Hiroko, KUBOTA, Kiyoshi

Volltext

3. 「日本における適正な安全性監視計画作成のためのタスクフォース」活動を終えて: チェックリストによる公表された安全性監視計画の検証と今後の課題について... von 古閑, 晃, 久保田, 潔

Volltext

より良い Pharmacovigilance Plan 策定に向けての提言 von 小宮山, 靖, 青木, 事成, 古閑, 晃, 久保田, 潔

Volltext